Brian Lawson Takes the Helm at the Board of Pharmacy Specialties
The American Pharmacists Association (APhA) recently made headlines with the announcement of
Brian Lawson, PharmD, ICE-CCP, as the new
Executive Director of the Board of Pharmacy Specialties (BPS). This decision comes after a rigorous national search intended to find an ideal candidate to lead this pivotal organization.
A Journey of Leadership
Lawson is no stranger to BPS, as he has made significant contributions during his tenure, which began in
2012. His journey through various leadership roles has provided him with a deep understanding of the organization’s inner workings. Prior to this appointment, he served as the
Interim Executive Director, allowing him to seamlessly step into this new position without missing a beat. His deep institutional knowledge and vision for the future are expected to usher in an era of continued progress for BPS.
Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, the
Executive Vice President and CEO of APhA, praised Lawson's credentials. He remarked, “Dr. Lawson is a highly accomplished association management executive and credentialing leader. He has served BPS in a variety of roles over the years and is perfectly positioned to guide BPS moving forward.” Hogue emphasized Lawson's track record of innovation and collaboration, which would certainly be instrumental in enhancing patient care across the pharmacy landscape.
Vision for the Future
As the new Executive Director, Lawson is responsible for steering BPS in its mission to improve patient care through board certification of pharmacists. With over
60,000 active pharmacist certifications across
15 specialties, BPS has established the gold standard in pharmacy board certification. Lawson’s extensive experience and strategic vision are expected to help build upon this strong foundation, ensuring that BPS continues to expand and innovate.
During his time with BPS, Lawson has held positions such as
Associate Executive Director and
Senior Director of Professional Affairs and International Engagement. His leadership in these roles has not only expanded BPS’s global influence but has also bolstered professional affairs and governance. His dedication has raised awareness for board-certified pharmacists worldwide, highlighting their essential role in healthcare.
As BPS continues to evolve, Lawson is prepared to embrace its challenges and opportunities. His deep understanding of both domestic and international pharmacy practice will serve him well as he guides BPS toward new horizons.
Conclusion
In a world where pharmacy practice and patient care standards are continuously evolving, the appointment of Brian Lawson as Executive Director of the Board of Pharmacy Specialties is a significant milestone. His experience and insight promise to enhance the role and recognition of certified pharmacists in the healthcare landscape. With this new leadership, the future of BPS looks brighter than ever, ensuring that patient care remains the focal point.
For more information about the Board of Pharmacy Specialties and its pivotal role in the pharmacy profession, please visit
BPS Website. For details regarding the American Pharmacists Association’s continuing efforts to advance the profession, go to
APhA Website.